AstraZeneca

Open: 67.71 Close: 67.33 Change: -0.38

How to get information about AstraZeneca Stock without reading the whole internet.

How much time have you spent trying to decide whether investing in AstraZeneca? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AstraZeneca are: AstraZeneca, cancer, …

Concept Map

Semantic Network

Stock Summary

AstraZeneca PLC focuses on the discovery, development, manufacture, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa,.

Today's Summary

British drugmaker filed a lawsuit on Friday in the U.S. Astrazeneca (AZN) concluded the recent trading session at $68.11, signifying a +0.15% move from its prior days close. Tagriso is AstraZecas biggest-selling drug.

Today's News

AstraZeneca Tagrisso set to be the leader in the lung cancer drug market. Tagriso is AstraZecas biggest-selling drug, making $5.44 billion in 2022, up 15% in 2021. AstraZeneca has the vision to redefine cancer care and, one day, eliminate cancer as a cause of death. Astrazeneca PLC ADR falls Friday, still outperforms market - MarketWatch. The AstraZeneca stock market closed 1.15% to $67.33 on what proved to be an all-around mixed trading session. AstraZeneca latest to Sue Biden Administration over IRAs Drug Price Negotiations. British drugmaker filed a lawsuit on Friday in the U.S. Astrazeneca (AZN) concluded the recent trading session at $68.11, signifying a +0.15% move from its prior days close. The company is jointly developing FPI-2068 with AstraZeneca under the companies multi-asset collaborati. Sales for AstraZenecas Tagrisso are anticipated to exceed $7 billion and hold a 48 percent share of the market of small molecules in lung cancer treatment by 2029. Lynparza, another small molecule from Astra Zeneca, is undergoing clinical trials. Astrazeneca ( AZN - Free Report ) reached $68.11, with a +0.15% movement compared to the previous day. Right now, Astrazenec possesses a Zacks Rank of #3 (Hold) AstraZeneca has 19 products that made sales of more than $500 million in 2022. UK government has ordered 100 million doses each of COVID-19 vaccine doses each.

Stock Profile

"AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Andexxa/Ondexxya, Atacand, Atacand HCT, Atacand Plus, Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and Zestril XR for cardiovascular, renal, and metabolism diseases; Accolate, Accoleit, Vanticon, Bevespi Aerosphere, Breztri Aerosphere, Bricanyl Respules and Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Rhinocort, Saphnelo, Symbicort, and Tezspire for respiratory and immunology; and Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. Its marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; and Personalis, Inc. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom."

Keywords

Are looking for the most relevant information about AstraZeneca? Investor spend a lot of time searching for information to make investment decisions in AstraZeneca. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AstraZeneca are: AstraZeneca, cancer, market, day, Astrazeneca, Tagrisso, lung, and the most common words in the summary are: astrazeneca, cancer, drug, vaccine, report, news, lung, . One of the sentences in the summary was: Astrazeneca (AZN) concluded the recent trading session at $68.11, signifying a +0.15% move from its prior days close. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #astrazeneca #cancer #drug #vaccine #report #news #lung.